179 related articles for article (PubMed ID: 29959272)
21. One-year follow-up of single-visit approach to cervical cancer prevention based on visual inspection with acetic acid wash and immediate cryotherapy in rural Thailand.
Chumworathayi B; Srisupundit S; Lumbiganon P; Limpaphayom KK
Int J Gynecol Cancer; 2008; 18(4):736-42. PubMed ID: 17949424
[TBL] [Abstract][Full Text] [Related]
22. A systematic review of the effects of visual inspection with acetic acid, cryotherapy, and loop electrosurgical excision procedures for cervical dysplasia in HIV-infected women in low- and middle-income countries.
Forhan SE; Godfrey CC; Watts DH; Langley CL
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3():S350-6. PubMed ID: 25768874
[TBL] [Abstract][Full Text] [Related]
23. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project.
Gaffikin L; Blumenthal PD; Emerson M; Limpaphayom K;
Lancet; 2003 Mar; 361(9360):814-20. PubMed ID: 12642047
[TBL] [Abstract][Full Text] [Related]
24. Health workers' perspectives on barriers and facilitators to implementing a new national cervical cancer screening program in Ethiopia.
Lott BE; Halkiyo A; Kassa DW; Kebede T; Dedefo A; Ehiri J; Madhivanan P; Carvajal S; Soliman A
BMC Womens Health; 2021 May; 21(1):185. PubMed ID: 33941159
[TBL] [Abstract][Full Text] [Related]
25. Using experience to create evidence: a mixed methods process evaluation of the new free family planning policy in Burkina Faso.
Browne L; Cooper S; Tiendrebeogo C; Bicaba F; Bila A; Bicaba A; Druetz T
Reprod Health; 2022 Mar; 19(1):67. PubMed ID: 35303898
[TBL] [Abstract][Full Text] [Related]
26. Barriers to Cervical Cancer Screening in Burkina Faso: Needs for Patient and Professional Education.
Compaore S; Ouedraogo CMR; Koanda S; Haynatzki G; Chamberlain RM; Soliman AS
J Cancer Educ; 2016 Dec; 31(4):760-766. PubMed ID: 26336956
[TBL] [Abstract][Full Text] [Related]
27. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
28. Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam.
Paul P; Winkler JL; Bartolini RM; Penny ME; Huong TT; Nga le T; Kumakech E; Mugisha E; Jeronimo J
Oncologist; 2013; 18 Suppl():6-12. PubMed ID: 24334477
[TBL] [Abstract][Full Text] [Related]
29. Effect of single-visit VIA and cryotherapy cervical cancer prevention program in Roi Et, Thailand: a preliminary report.
Chumworathayi B; Blumenthal PD; Limpaphayom KK; Kamsa-Ard S; Wongsena M; Supaatakorn P
J Obstet Gynaecol Res; 2010 Feb; 36(1):79-85. PubMed ID: 20178531
[TBL] [Abstract][Full Text] [Related]
30. Prevalence, Predictors, and Same Day Treatment of Positive VIA Enhanced by Digital Cervicography and Histopathology Results in a Cervical Cancer Prevention Program in Cameroon.
DeGregorio GA; Bradford LS; Manga S; Tih PM; Wamai R; Ogembo R; Sando Z; Liu Y; Schwaiger C; Rao SR; Kalmakis K; Kennedy Sheldon L; Nulah K; Welty E; Welty T; Ogembo JG
PLoS One; 2016; 11(6):e0157319. PubMed ID: 27280882
[TBL] [Abstract][Full Text] [Related]
31. Women's experiences in a community-based screen-and-treat cervical cancer prevention program in rural Malawi: a qualitative study.
Lee F; Bula A; Chapola J; Mapanje C; Phiri B; Kamtuwange N; Tsidya M; Tang J; Chinula L
BMC Cancer; 2021 Apr; 21(1):428. PubMed ID: 33882885
[TBL] [Abstract][Full Text] [Related]
32. CRYOTHERAPY FOLLOWING VISUAL INSPECTION WITH ACETIC ACID AND LUGOL'S IODINE (VIA/VILI) IN KHWISERO, WESTERN KENYA: LESSON FROM THE FIELD AFFECTING POLICY AND PRACTICE.
Ngichabe SK; Muthaura PN; Murungi C; Muyoka J; Omenge E; Muchiri L
East Afr Med J; 2013 Oct; 90(10):316-23. PubMed ID: 26862641
[TBL] [Abstract][Full Text] [Related]
33. Health systems challenges in cervical cancer prevention program in Malawi.
Maseko FC; Chirwa ML; Muula AS
Glob Health Action; 2015; 8():26282. PubMed ID: 25623612
[TBL] [Abstract][Full Text] [Related]
34. Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services: a protocol for a stepped-wedge cluster randomized trial in Kenya.
Shin MB; Oluoch LM; Barnabas RV; Baynes C; Fridah H; Heitner J; Kerubo MB; Ngure K; Pinder LF; Thomas KK; Mugo NR; Gimbel S
Implement Sci; 2023 Jun; 18(1):26. PubMed ID: 37365575
[TBL] [Abstract][Full Text] [Related]
35. Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana.
Blumenthal PD; Gaffikin L; Deganus S; Lewis R; Emerson M; Adadevoh S;
Am J Obstet Gynecol; 2007 Apr; 196(4):407.e1-8; discussion 407.e8-9. PubMed ID: 17403438
[TBL] [Abstract][Full Text] [Related]
36. Feasibility, acceptability, and effectiveness of visual inspection of the cervix with acetic acid and cryotherapy for dysplasia in Nigeria.
Adefuye PO; Dada OA; Adefuye BO; Shorunmu TO; Akinyemi BO; Idowu-Ajiboye BO
Int J Gynaecol Obstet; 2015 Apr; 129(1):62-6. PubMed ID: 25593107
[TBL] [Abstract][Full Text] [Related]
37. Safety, feasibility, and acceptability of visual inspection with acetic acid and immediate treatment with cryotherapy in rural Laos.
Phongsavan K; Phengsavanh A; Wahlström R; Marions L
Int J Gynaecol Obstet; 2011 Sep; 114(3):268-72. PubMed ID: 21752376
[TBL] [Abstract][Full Text] [Related]
38. Efficacy, safety, acceptability and affordability of cryotherapy: a review of current literature.
McClung EC; Blumenthal PD
Minerva Ginecol; 2012 Apr; 64(2):149-71. PubMed ID: 22481625
[TBL] [Abstract][Full Text] [Related]
39. Estimating the costs of cervical cancer screening in high-burden Sub-Saharan African countries.
Mvundura M; Tsu V
Int J Gynaecol Obstet; 2014 Aug; 126(2):151-5. PubMed ID: 24792401
[TBL] [Abstract][Full Text] [Related]
40. Mobilizing stakeholders for implant removals in Burkina Faso using landscape assessment data.
Tiendrebeogo J; Arnold B; Ouedraogo Y; Haws R; Garane LP; Ouedraogo V; Gouem M; Coulibaly A; Bougma M
BMC Womens Health; 2024 May; 24(1):301. PubMed ID: 38769558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]